Showing results (21-30 of 101) with videos related to
Sort By:
Pageof 11
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2014
Late effects of oxaliplatin-induced peripheral neuropathy (LEON)--cross-sectional cohort study of patients with colorectal cancer surviving at least 2 yearsSunita Padman, Jaein Lee, Rajiv Kumar, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 15, 2016
Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched studyIlya Kister, Tim Spelman, Raed Alroughani, et al.Clinical Epigenetics|February 11, 2023
Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosisMaria Pia Campagna, Alexandre Xavier, Jim Stankovich, et al.Cells|May 13, 2023
Functional Characterisation of the Circular RNA, circHTT(2-6), in Huntington's DiseaseLaura Gantley, Brett W Stringer, Vanessa M Conn, et al.Clinical Immunology (Orlando, Fla.)|February 6, 2014
The autoimmune disease-associated transcription factors EOMES and TBX21 are dysregulated in multiple sclerosis and define a molecular subtype of diseaseGrant P Parnell, Prudence N Gatt, Malgorzata Krupa, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 13, 2020
Real-world effectiveness of cladribine for Australian patients with multiple sclerosis: An MSBase registry substudyNathaniel Lizak, Suzanne Hodgkinson, Ernest Butler, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 16, 2013
Ribosomal protein S6 mRNA is a biomarker upregulated in multiple sclerosis, downregulated by interferon treatment, and affected by seasonGrant P Parnell, Prudence N Gatt, Fiona C McKay, et al.Therapeutic Advances in Neurological Disorders|February 28, 2024
Long-term clinical outcomes in patients with multiple sclerosis who are initiating disease-modifying therapy with natalizumab compared with BRACETD first-line therapiesHelmut Butzkueven, Tomas Kalincik, Francesco Patti, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|September 4, 2024
Prognostic significance of paramagnetic rim lesions in multiple sclerosis: A systematic reviewAdon Toru Asahina, Joe Lu, Pooja Chugh, et al.Neurology|August 4, 2023
Evaluation of Cell-Specific Epigenetic Age Acceleration in People With Multiple SclerosisVicki Maltby, Alexandre Xavier, Ewoud Ewing, et al.Pageof 11